Clinical Trial Update: Haploidentical Donor vs mMUD in Hematological Malignancies [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing haploidentical donor transplantation to matched unrelated donor transplantation in hematologic malignancies has completed, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Snippet

Sponsor: DKMS gemeinnützige GmbH | Conditions: AML, ALL | Phase 2, Phase 3 | Status: COMPLETED